- Home
- SSTI vs ABOS Comparison
SSTI vs ABOS Comparison
Compare SSTI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSTI
- ABOS
- Stock Information
- Founded
- SSTI 1996
- ABOS 1996
- Country
- SSTI United States
- ABOS United States
- Employees
- SSTI N/A
- ABOS N/A
- Industry
- SSTI Computer Software: Prepackaged Software
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- SSTI Technology
- ABOS Health Care
- Exchange
- SSTI Nasdaq
- ABOS Nasdaq
- Market Cap
- SSTI 161.8M
- ABOS 171.8M
- IPO Year
- SSTI 2017
- ABOS 2021
- Fundamental
- Price
- SSTI $11.19
- ABOS $2.53
- Analyst Decision
- SSTI Buy
- ABOS Strong Buy
- Analyst Count
- SSTI 7
- ABOS 4
- Target Price
- SSTI $21.83
- ABOS $9.00
- AVG Volume (30 Days)
- SSTI 70.3K
- ABOS 245.2K
- Earning Date
- SSTI 11-12-2024
- ABOS 11-12-2024
- Dividend Yield
- SSTI N/A
- ABOS N/A
- EPS Growth
- SSTI N/A
- ABOS N/A
- EPS
- SSTI N/A
- ABOS N/A
- Revenue
- SSTI $104,665,000.00
- ABOS N/A
- Revenue This Year
- SSTI $15.81
- ABOS N/A
- Revenue Next Year
- SSTI $5.99
- ABOS N/A
- P/E Ratio
- SSTI N/A
- ABOS N/A
- Revenue Growth
- SSTI 19.39
- ABOS N/A
- 52 Week Low
- SSTI $9.33
- ABOS $2.08
- 52 Week High
- SSTI $26.92
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- SSTI 47.67
- ABOS 41.30
- Support Level
- SSTI $9.33
- ABOS $2.85
- Resistance Level
- SSTI $12.82
- ABOS $3.36
- Average True Range (ATR)
- SSTI 0.69
- ABOS 0.25
- MACD
- SSTI 0.16
- ABOS -0.04
- Stochastic Oscillator
- SSTI 53.31
- ABOS 1.19
About SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.